ACADIAN ASSET MANAGEMENT LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 71 filers reported holding INSYS THERAPEUTICS INC NEW in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2017$2,000
-50.0%
166
-52.6%
0.00%
Q4 2016$4,0000.0%3500.0%0.00%
Q3 2016$4,0000.0%3500.0%0.00%
Q2 2016$4,000
-33.3%
3500.0%0.00%
Q1 2016$6,000
-40.0%
3500.0%0.00%
Q4 2015$10,000
+11.1%
350
+5.4%
0.00%
Q3 2015$9,000
-98.8%
332
-98.5%
0.00%
-100.0%
Q2 2015$774,000
+6936.4%
21,561
+8098.1%
0.00%
Q1 2014$11,000
-98.4%
263
-98.5%
0.00%
-100.0%
Q4 2013$670,000
+106.8%
17,345
+87.1%
0.00%
+100.0%
Q3 2013$324,0009,2710.00%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q3 2013
NameSharesValueWeighting ↓
HealthInvest Partners AB 788,175$10,199,0004.68%
SCOPIA CAPITAL MANAGEMENT LP 8,987,313$116,296,0002.40%
Antipodean Advisors LLC 305,294$3,951,0002.39%
Freshford Capital Management, LLC 475,984$6,159,0001.81%
Folger Hill Asset Management LP 1,597,945$20,677,0001.61%
JW Asset Management, LLC 150,638$1,949,0001.55%
12 West Capital Management LP 623,791$8,072,0001.30%
Orbimed Advisors 4,688,240$60,666,0000.63%
CYPRESS FUNDS LLC 135,584$1,754,0000.41%
Rock Springs Capital Management LP 365,500$4,730,0000.35%
View complete list of INSYS THERAPEUTICS INC NEW shareholders